JadiCell™

· Breathe Biologics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JadiCell™, covering 2026-03-19 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Safety and Potential Therapeutic Activity of JadiCell™, an Investigational Umbilical Cord-Derived Mesenchymal Stem Cell Therapy, in Patients Diagnosed With Acute Respiratory Distress Syndrome (ARDS). [Phase 3]

See pricing